Is There Still Time To Buy Reckitt Benckiser Group Plc?

Can Reckitt Benckiser Group Plc (LON: RB) move higher, or are the company’s shares overvalued?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Right now I’m looking at some of the most popular companies in the FTSE 100 and wider market to try and establish if there is still time for investors to buy in.

Today I’m looking at Reckitt Benckiser (LSE: RB) to ascertain if its share price has the potential to push higher. 

Current market sentiment
reckitt.benckiser

The best place to start assessing whether or not Reckitt’s share price has the potential to push higher, is to take a look at the market’s current opinion towards the company.

At present, it would appear that the market is upbeat about Reckitt’s future prospects, as the company’s defensive nature means that sales and profits are likely to remain strong, despite global geopolitical events and economic instability.

What’s more, Reckitt’s plans for growth have impressed investors as management seeks to manoeuvre the business towards the high-margin consumer health market and away from low-margin consumer products.

Upcoming catalysts

Indeed, Reckitt’s management is keen to focus on the company’s 19 “power brands”, which are sold in almost 200 countries and including household staples such as Finish dishwasher tablets and Gaviscon heartburn remedy. These investment plans and Reckitt’s strategy shift are likely to be the company’s main catalysts going forward. 

Other growth initiatives include acquisitions and spin offs. For example, Reckitt acquired the K-Y brand of sexual lubricants from Johnson & Johnson in March, a move designed to build its presence in the sexual health market.

Additionally, Reckitt is considering a spin off of its pharmaceuticals division, which management put under strategic review in October. Reckitt’s pharmaceutical arm produces the Suboxone heroin substitute.

Still, aside from acquisitions there are few catalysts that are likely to affect Reckitt going forward, apart from the company’s half-year results, which are scheduled to be released around the middle of July.

Reckitt’s half-year results should show investors how the company’s acquisition plan is progressing and management is likely to update the market on the company’s acquisition strategy going forward.  

Valuation

Due to Reckitt’s defensive nature, investors are prepared to pay a premium for the company’s shares. Reckitt trades at a historic P/E of 17.7 compared to the wider FTSE 100, which trades at a P/E of 13.6.

However, in my opinion, Reckitt’s premium over the wider market is warranted as the firm’s position within the consumer health market, means that the company is throwing off more cash than it knows what to do with.

Net cash from operating activities rose more than 12% last year, to £2.1bn giving the company money to grow the business or return to shareholders. With this much cash being generated by the company, it’s likely that Reckitt will be around for some time to come and growth will continue.

Foolish summary

So overall, I feel that there is still time to buy Reckitt Benckiser.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert does not own any share mentioned within this article. 

More on Investing Articles

Investing Articles

5 steps to start buying shares with under £500

Learn how this writer would start buying shares with a few hundred pounds in a handful of steps, if he…

Read more »

Young happy white woman loading groceries into the back of her car
Investing Articles

The FTSE 100 offers some great bargains. Is this one?

Our writer digs into one FTSE 100 share that has had a rough 2024 to date, ahead of its interim…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

£9,000 of savings? Here’s my 3-step approach to aim for £1,794 in passive income

Christopher Ruane walks through the practical steps he would take to try and turn £9,000 into a sizeable passive income…

Read more »

Group of young friends toasting each other with beers in a pub
Investing Articles

I’d buy 29,412 shares of this UK dividend stock for £150 a month in passive income

Insiders have been buying this dividend stock, which offers an 8.5% yield. Roland Head explains why he’d choose the shares…

Read more »

Red briefcase with the words Budget HM Treasury embossed in gold
Investing Articles

Could the new UK budget spell growth for these 6 FTSE stocks? I think so!

Mark David Hartley considers six UK stocks that could enjoy growth off the back of new measures announced in the…

Read more »

Investing Articles

With a 6.6% yield, is now the right time to add this income stock to my ISA?

Our writer’s looking to boost his Stocks and Shares ISA. With this in mind, he’s debating whether to buy a…

Read more »

Dividend Shares

This blue-chip FTSE stock just fell 12.5% in a day. Is it time to consider buying?

Smith & Nephew is a well-known, blue-chip FTSE stock with a decent dividend yield. And its share price just dropped…

Read more »

Investing Articles

At 72p, the Vodafone share price looks to be at least 33% undervalued to me

Our writer looks at a number of valuation measures to determine whether the Vodafone share price reflects the fair value…

Read more »